Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors
Advanced AI Platform Enables More Accurate Site Selection and Faster Study Startup Across Key Therapeutic Areas Partnership brings real-time site identification, feasibility, activation and automated trial optimization to Biorasi’s sponsor clients, reducing trial delays and improving cost effectiveness LAGUNA BEACH,... Read More →
SafeHeal® Receives European Marketing Approval Under MDR for Colovac® Anastomosis Protection Technology
PARIS, France — SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced that it has been granted European Union marketing approval for its Colovac device under the new Medical Device Regulation (EU MDR 2017/745, Medical Devices,... Read More →
IRUBIS Appoints Matthias Eggers as New CEO to Lead USA Expansion and Commercial Scale-Up
Munich, Germany – (August 14, 2025) – IRUBIS GmbH, a life science tools startup pioneering innovation in real-time bioprocess analytics, today announced the appointment of Matthias Eggers as Chief Executive Officer. Matthias succeeds Anja Müller, former CEO of IRUBIS, who... Read More →
RIVANNA secures $800,000 Virginia Catalyst Grant alongside matching funds to advance AI-enabled ultrasound platform for neuraxial anesthesia
CHARLOTTESVILLE, Va., Aug. 14, 2025 /PRNewswire/ — RIVANNA®, developers of world-first imaging-based medical technologies, was recently awarded grant funding valued at $800,000 from the Virginia Catalyst Program to advance the Accuro® 3S diagnostic ultrasound system. RIVANNA worked in collaboration with... Read More →
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
Exton, Pa., Aug. 14, 2025 (GLOBE NEWSWIRE) — Lungpacer Medical Inc., a medical technology company focused on neurostimulation therapies for critically ill patients, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-on Payment... Read More →
Diagnostic Biochips, Inc. awarded $500,000 in non-dilutive grant funding from the Maryland Stem Cell Research Fund (MSCRF)
Brian Jamieson founded Diagnostic Biochips to unlock the inner workings of the brain. Based in Glen Burnie, the medical equipment manufacturing company develops tiny sensors that can be implanted to study electrical brain activity. The goal? To help find cures... Read More →
Digital Health Platform Naluri nets $ 5M Fund to Accelerate Growth
Naluri, Southeast Asia’s leading digital health platform and wellbeing provider has reported the successful closing of $ 5 million Series B equity funding. TELUS Global Ventures – through the Pollinator Fund for Good, the strategic impact investment arm of world-leading... Read More →
Cardiosense pairs advanced sensors with AI for its heart failure wearable
Dr. John Martin has a special perspective on medical device development as a practicing surgeon, medical device executive, and a patient who once found cancer in his own body while testing Butterfly Network’s technology. Martin is now the portable ultrasound... Read More →
Following FDA Announcement, Teal Health’s Teal Wand™ for At-Home Cervical Cancer Screening is Now Available, Starting in California
The company, which has a waitlist of more than 32,000, is now available in California, with plans to expand into more states and be national before the end of 2026 SAN FRANCISCO, Aug. 12, 2025 /PRNewswire/ — Teal Health®, a... Read More →
FDA Grants 510(k) Clearance for Sonic Incytes’ Velacur ONE™, AI-guided point of care ultrasound for the management of chronic liver diseases
VANCOUVER, British Columbia–(BUSINESS WIRE)–Sonic Incytes Medical Corp, proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Velacur ONE™, its point-of-care ultrasound elastography device. Building on the success of its original model, Velacur™, Velacur ONE™... Read More →